UFP Technologies (UFPT) Q2 EPS Jumps 27%
UFP Technologies (NASDAQ:UFPT), a designer and manufacturer of engineered products for medical devices and other specialty markets, released its earnings results for the second quarter of fiscal 2025 on August 5, 2025. The most significant news was a record quarter for profitability, with non-GAAP earnings per share rising well above analyst estimates. However, revenue (GAAP) narrowly missed consensus forecasts. The company reported EPS (non-GAAP) of $2.50, beating expectations by $0.25 on a non-GAAP basis, though revenue (GAAP) of $151.2 million was just shy of the $151.554 million estimate. Overall, the quarter demonstrated continued momentum in the medical technology segment, strong acquisition contributions, and solid cost controls, tempered by some margin pressure from labor issues.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
UFP Technologies specializes in manufacturing components and packaging for medical devices, orthopedic products, infection prevention gear, and certain non-medical uses. Its core expertise is in specialty materials and advanced manufacturing, serving medical device makers and other industry clients worldwide. The business supplies single-use and single-patient components for a range of healthcare applications, which makes it a critical partner for infection control, surgical, wound care, and orthopedic solutions.
Source Fool.com
